Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Transplant Proc ; 52(2): 549-552, 2020 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-32029312

RESUMO

BACKGROUND: Sarcopenia is defined as the loss of muscle mass and function. Our aim is to evaluate the degree of sarcopenia by measuring the patients on the waiting list for liver transplantation and its influence on the different post-liver transplant outcomes in our group. METHODS: The psoas muscle index (PMI, cm2/m2) was calculated (right psoas muscle area [cm2]/the square of the body height [m2]) in 57 patients on the waiting list for liver transplantation in our center, and the post-transplant variables relevant to our study were collected. RESULTS: The 57 recipients had a mean age of 57 years (range, 35-73) and had a mean of 7.4 months (range, 0-39) on the liver transplant waiting list. The mean psoas muscle index was 2.39 (range, 1-4), and the mean body mass index was 28.01kg/m2 (range, 22-36). After multivariate analysis we found a positive correlation between the PMI and the body mass index of the recipients (r = 0.320, P = .017), intensive care unit length of stay, and donor age (r = 0.319, P = .042), and between cold ischemia time and graft survival (r = 0.366, P = .009). We found no correlation in our sample between PMI and post-liver transplant complications either in terms of graft or patient survival. CONCLUSION: PMI is not representative of total muscle mass and sarcopenia and is not effective in adequately predicting the survival of patients on the waiting list for liver transplantation.


Assuntos
Hepatopatias/cirurgia , Transplante de Fígado/efeitos adversos , Complicações Pós-Operatórias/etiologia , Sarcopenia/diagnóstico , Índice de Gravidade de Doença , Adulto , Idoso , Índice de Massa Corporal , Feminino , Humanos , Unidades de Terapia Intensiva , Hepatopatias/complicações , Masculino , Pessoa de Meia-Idade , Análise Multivariada , Período Pré-Operatório , Músculos Psoas/patologia , Estudos Retrospectivos , Medição de Risco/métodos , Fatores de Risco , Sarcopenia/complicações , Resultado do Tratamento , Listas de Espera
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA